Propranolol in the treatment of acute myocardial infarction. Effect on myocardial oxygenation and hemodynamics.
D000208:Acute Disease; D000328:Adult; D000368:Aged; D001794:Blood Pressure / Q000187:drug effects; D006328:Cardiac Catheterization; D002302:Cardiac Output / Q000187:drug effects; D002986:Clinical Trials as Topic; D003326:Coronary Circulation / Q000187:drug effects*; D004548:Elasticity; D005260:Female; D005947:Glucose / Q000378:metabolism; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D007773:Lactates / Q000378:metabolism; D008012:Lidocaine / Q000627:therapeutic use; D008297:Male; D008614:Meperidine / Q000627:therapeutic use; D008875:Middle Aged; D009020:Morphine / Q000627:therapeutic use; D009203:Myocardial Infarction / Q000188:drug therapy*; D009206:Myocardium / Q000378:metabolism*; D010101:Oxygen Consumption / Q000187:drug effects*; D011433:Propranolol / Q000627:therapeutic use*; D011773:Pyruvates / Q000378:metabolism; D014655:Vascular Resistance / Q000187:drug effects
D007773:Lactates; D011773:Pyruvates; D009020:Morphine; D008012:Lidocaine; D008614:Meperidine; D011433:Propranolol; D005947:Glucose